Matches in Wikidata for { <http://www.wikidata.org/entity/Q90148371> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- Q90148371 description "artículu científicu espublizáu en setiembre de 2019" @default.
- Q90148371 description "scientific article published on 17 September 2019" @default.
- Q90148371 description "wetenschappelijk artikel" @default.
- Q90148371 description "наукова стаття, опублікована 17 вересня 2019" @default.
- Q90148371 name "Guadecitabine Plus Ipilimumab in Unresectable Melanoma: The NIBIT-M4 Clinical Trial" @default.
- Q90148371 name "Guadecitabine Plus Ipilimumab in Unresectable Melanoma: The NIBIT-M4 Clinical Trial" @default.
- Q90148371 type Item @default.
- Q90148371 label "Guadecitabine Plus Ipilimumab in Unresectable Melanoma: The NIBIT-M4 Clinical Trial" @default.
- Q90148371 label "Guadecitabine Plus Ipilimumab in Unresectable Melanoma: The NIBIT-M4 Clinical Trial" @default.
- Q90148371 prefLabel "Guadecitabine Plus Ipilimumab in Unresectable Melanoma: The NIBIT-M4 Clinical Trial" @default.
- Q90148371 prefLabel "Guadecitabine Plus Ipilimumab in Unresectable Melanoma: The NIBIT-M4 Clinical Trial" @default.
- Q90148371 P1433 Q90148371-6EB3F796-3A9C-41A4-8CC0-61E5FE1E5054 @default.
- Q90148371 P1476 Q90148371-13DF0C71-3EAE-438D-8D5D-061A1B623166 @default.
- Q90148371 P2093 Q90148371-03BC2E56-2D79-44DB-AFC9-B0557901BA69 @default.
- Q90148371 P2093 Q90148371-03F7F95D-9D4E-4EA9-9544-3664064C5253 @default.
- Q90148371 P2093 Q90148371-161D0D3F-6168-474B-B924-21F7BACE5EFA @default.
- Q90148371 P2093 Q90148371-1625F995-5081-40CB-B07E-99D968A86E39 @default.
- Q90148371 P2093 Q90148371-2577B36A-0B15-4563-8022-4084B46839C7 @default.
- Q90148371 P2093 Q90148371-4EB0024E-85D4-4C83-BF9E-8A1824BE783F @default.
- Q90148371 P2093 Q90148371-53D64D55-5FEA-4D43-9181-2174D9204D74 @default.
- Q90148371 P2093 Q90148371-54085D2B-C413-4A00-8843-D4DF03D7517B @default.
- Q90148371 P2093 Q90148371-548364B7-16DE-4F07-9F32-E63EA7FB75B0 @default.
- Q90148371 P2093 Q90148371-589B62DD-FAE4-4B8C-BBAB-A6300DABD5BC @default.
- Q90148371 P2093 Q90148371-6303ACE8-3060-4A71-A25F-0394462891C2 @default.
- Q90148371 P2093 Q90148371-7D63688A-D22F-4B8B-877F-9B7CBDC46006 @default.
- Q90148371 P2093 Q90148371-83E6009F-D3BC-4725-824C-EE5BEE5B252E @default.
- Q90148371 P2093 Q90148371-849DFD9A-3EAD-4E32-827F-B34924288E8A @default.
- Q90148371 P2093 Q90148371-AA8C360E-22AB-494D-A24E-0ADD455C12C2 @default.
- Q90148371 P2093 Q90148371-B0AEC7A8-B4A8-4E94-AE52-72715EE4E332 @default.
- Q90148371 P2093 Q90148371-BDC8808E-49D6-4F8E-9642-C274799D873C @default.
- Q90148371 P2093 Q90148371-C648D4B3-3ED6-4D22-9C08-54BDAEC9346E @default.
- Q90148371 P2093 Q90148371-F5CDB254-6B6C-43E5-8974-D3FA3C13EB3F @default.
- Q90148371 P2093 Q90148371-F679BF9D-669B-41AD-A7FE-84B6B2C9E54C @default.
- Q90148371 P2093 Q90148371-F80FEFB7-789F-4663-A9AE-B310FB1E9CBD @default.
- Q90148371 P304 Q90148371-F718FF27-9C61-43BA-99AA-AF755E0C0E85 @default.
- Q90148371 P31 Q90148371-F9CC7AD4-3B16-4EAC-A946-F40CE2521C12 @default.
- Q90148371 P356 Q90148371-62E65BA1-7A66-484F-A698-E2DADFCB0F85 @default.
- Q90148371 P433 Q90148371-48DF5E29-DA06-4095-9A31-D32524244C60 @default.
- Q90148371 P478 Q90148371-FD85F9DA-AE1B-4C5C-9E93-293F56DE248D @default.
- Q90148371 P50 Q90148371-3D09F3C2-8C43-43AE-AD12-B98B966E7772 @default.
- Q90148371 P50 Q90148371-412C0697-0DBA-416D-9547-D817A68C9C62 @default.
- Q90148371 P50 Q90148371-5D1B6F8B-9F84-4C19-BB3B-4C86306B7F51 @default.
- Q90148371 P50 Q90148371-8CD1EB43-60DA-484C-8CFC-90D64AD6F46C @default.
- Q90148371 P50 Q90148371-9A3B56B8-F9E0-45B9-8BD7-17F17CDA433D @default.
- Q90148371 P50 Q90148371-AC3757E5-C4A0-4F27-8A51-376B12D10801 @default.
- Q90148371 P577 Q90148371-A9103EE6-E9CD-4F7E-8D91-03C399204779 @default.
- Q90148371 P698 Q90148371-F097D8FC-DADA-4305-82A0-9A90EC398F18 @default.
- Q90148371 P356 1078-0432.CCR-19-1335 @default.
- Q90148371 P698 31530631 @default.
- Q90148371 P1433 Q332253 @default.
- Q90148371 P1476 "Guadecitabine Plus Ipilimumab in Unresectable Melanoma: The NIBIT-M4 Clinical Trial" @default.
- Q90148371 P2093 "Alessia Covre" @default.
- Q90148371 P2093 "Amelie Nemc" @default.
- Q90148371 P2093 "Andrea Anichini" @default.
- Q90148371 P2093 "Andrea Lazzeri" @default.
- Q90148371 P2093 "Anna Maria Di Giacomo" @default.
- Q90148371 P2093 "Aram Oganesian" @default.
- Q90148371 P2093 "Carolina Fazio" @default.
- Q90148371 P2093 "Clelia Miracco" @default.
- Q90148371 P2093 "Giovanni Amato" @default.
- Q90148371 P2093 "James Lowder" @default.
- Q90148371 P2093 "Laetitia Lacroix" @default.
- Q90148371 P2093 "Luca Sigalotti" @default.
- Q90148371 P2093 "Michele Maio" @default.
- Q90148371 P2093 "Mohammad Azab" @default.
- Q90148371 P2093 "Monica Valente" @default.
- Q90148371 P2093 "Ornella Cutaia" @default.
- Q90148371 P2093 "Riccardo Danielli" @default.
- Q90148371 P2093 "Sandra Coral" @default.
- Q90148371 P2093 "Santa Monterisi" @default.
- Q90148371 P2093 "Wolf H Fridman" @default.
- Q90148371 P2093 "Zlatko Trajanoski" @default.
- Q90148371 P304 "7351-7362" @default.
- Q90148371 P31 Q13442814 @default.
- Q90148371 P356 "10.1158/1078-0432.CCR-19-1335" @default.
- Q90148371 P433 "24" @default.
- Q90148371 P478 "25" @default.
- Q90148371 P50 Q30243364 @default.
- Q90148371 P50 Q40020459 @default.
- Q90148371 P50 Q44736865 @default.
- Q90148371 P50 Q48975669 @default.
- Q90148371 P50 Q57444592 @default.
- Q90148371 P50 Q90148367 @default.
- Q90148371 P577 "2019-09-17T00:00:00Z" @default.
- Q90148371 P698 "31530631" @default.